• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LASER; EXCIMER LASER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LASER; EXCIMER LASER SYSTEM Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Unspecified Eye / Vision Problem (4471)
Event Type  Injury  
Event Description
Follow on surgery 3x cxl; lasik surgery in (b)(6) 2006.Diagnosed with corneal ectasia in 2011.Prior scans showed a high risk and no warning of this risk.Follow on surgery of collagen cross linking (cxl) to both eyes, right eye in 2012 and 2022, left eye in 2015.Continuous use of hyloforte, fml and opatanol for ongoing symptoms since 2011.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LASER
Type of Device
EXCIMER LASER SYSTEM
MDR Report Key13783608
MDR Text Key287394204
Report NumberMW5108192
Device Sequence Number1
Product Code LZS
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Patient Sequence Number1
Treatment
CETIRIZINE HYDROCHLORIDE ; FML OPATANOL ; HYLOFORTE; SYMBICORT ; TURBO INHALER
Patient Outcome(s) Other; Required Intervention;
Patient SexFemale
Patient RaceWhite
-
-